Global Neuromodulation Devices and Implantable Infusion Pumps Market Insights and Forecast to 2027

1 Study Coverage

• 1.1 Neuromodulation Devices and Implantable Infusion Pumps Product Introduction
• 1.2 Market by Type
  • 1.2.1 Global Neuromodulation Devices and Implantable Infusion Pumps Market Size Growth Rate by Type
  • 1.4.2 Spinal Cord Stimulation
  • 1.4.3 Deep Brain Stimulation
  • 1.2.4 Sacral Nerve Stimulation
  • 1.2.5 Vagal Nerve Stimulation
  • 1.2.6 Gastric Stimulation
  • 1.2.7 Transcranial Magnetic Stimulation
  • 1.2.8 Transcutaneous Electrical Stimulation
  • 1.2.9 Other
• 1.3 Market by Application
  • 1.3.1 Global Neuromodulation Devices and Implantable Infusion Pumps Market Size Growth Rate by Application
  • 1.3.2 Parkinson's Disease
  • 1.3.3 Epilepsy
  • 1.3.4 Pain
  • 1.3.5 Other
• 1.4 Study Objectives
• 1.5 Years Considered

2 Executive Summary

• 2.1 Global Neuromodulation Devices and Implantable Infusion Pumps Sales Estimates and Forecasts 2016-2027
• 2.2 Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Estimates and Forecasts 2016-2027
• 2.3 Global Neuromodulation Devices and Implantable Infusion Pumps Revenue by Region: 2016 VS 2021 VS 2027
• 2.4 Global Top Neuromodulation Devices and Implantable Infusion Pumps Regions by Sales
  • 2.4.1 Global Top Neuromodulation Devices and Implantable Infusion Pumps Regions by Sales (2016-2021)
  • 2.4.2 Global Top Neuromodulation Devices and Implantable Infusion Pumps Regions by Sales (2022-2027)
• 2.5 Global Top Neuromodulation Devices and Implantable Infusion Pumps Regions by Revenue
  • 2.5.1 Global Top Neuromodulation Devices and Implantable Infusion Pumps Regions by Revenue (2016-2021)
  • 2.5.2 Global Top Neuromodulation Devices and Implantable Infusion Pumps Regions by Revenue (2022-2027)
• 2.6 North America
• 2.7 Europe
• 2.8 Asia-Pacific
• 2.9 Latin America
• 2.10 Middle East & Africa

3 Competition by Manufacturers

• 3.1 Global Neuromodulation Devices and Implantable Infusion Pumps Sales by Manufacturers
  • 3.1.1 Global Top Neuromodulation Devices and Implantable Infusion Pumps Manufacturers by Sales (2016-2021)
  • 3.1.2 Global Top Neuromodulation Devices and Implantable Infusion Pumps Manufacturers Market Share by Sales (2016-2021)
  • 3.1.3 Global Top 10 and Top 5 Companies by Neuromodulation Devices and Implantable Infusion Pumps Sales in 2020
• 3.2 Global Neuromodulation Devices and Implantable Infusion Pumps Revenue by Manufacturers
  • 3.2.1 Global Top Neuromodulation Devices and Implantable Infusion Pumps Manufacturers by Revenue (2016-2021)
  • 3.2.2 Global Top Neuromodulation Devices and Implantable Infusion Pumps Manufacturers Market Share by Revenue (2016-2021)
  • 3.2.3 Global Top 10 and Top 5 Companies by Neuromodulation Devices and Implantable Infusion Pumps Revenue in 2020
• 3.3 Global Neuromodulation Devices and Implantable Infusion Pumps Sales Price by Manufacturers
• 3.4 Analysis of Competitive Landscape
  • 3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
  • 3.4.2 Global Neuromodulation Devices and Implantable Infusion Pumps Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
  • 3.4.3 Global Neuromodulation Devices and Implantable Infusion Pumps Manufacturers Geographical Distribution
• 3.5 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

• 4.1 Global Neuromodulation Devices and Implantable Infusion Pumps Sales by Type
  • 4.1.1 Global Neuromodulation Devices and Implantable Infusion Pumps Historical Sales by Type (2016-2021)
  • 4.1.2 Global Neuromodulation Devices and Implantable Infusion Pumps Forecasted Sales by Type (2022-2027)
  • 4.1.3 Global Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Type (2016-2027)
• 4.2 Global Neuromodulation Devices and Implantable Infusion Pumps Revenue by Type
  • 4.2.1 Global Neuromodulation Devices and Implantable Infusion Pumps Historical Revenue by Type (2016-2021)
  • 4.2.2 Global Neuromodulation Devices and Implantable Infusion Pumps Forecasted Revenue by Type (2022-2027)
  • 4.2.3 Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share by Type (2016-2027)
• 4.3 Global Neuromodulation Devices and Implantable Infusion Pumps Price by Type
  • 4.3.1 Global Neuromodulation Devices and Implantable Infusion Pumps Price by Type (2016-2021)
  • 4.3.2 Global Neuromodulation Devices and Implantable Infusion Pumps Price Forecast by Type (2022-2027)

5 Market Size by Application

• 5.1 Global Neuromodulation Devices and Implantable Infusion Pumps Sales by Application
  • 5.1.1 Global Neuromodulation Devices and Implantable Infusion Pumps Historical Sales by Application (2016-2021)
  • 5.1.2 Global Neuromodulation Devices and Implantable Infusion Pumps Forecasted Sales by Application (2022-2027)
  • 5.1.3 Global Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Application (2016-2027)
• 5.2 Global Neuromodulation Devices and Implantable Infusion Pumps Revenue by Application
  • 5.2.1 Global Neuromodulation Devices and Implantable Infusion Pumps Historical Revenue by Application (2016-2021)
  • 5.2.2 Global Neuromodulation Devices and Implantable Infusion Pumps Forecasted Revenue by Application (2022-2027)
  • 5.2.3 Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share by Application (2016-2027)
• 5.3 Global Neuromodulation Devices and Implantable Infusion Pumps Price by Application
  • 5.3.1 Global Neuromodulation Devices and Implantable Infusion Pumps Price by Application (2016-2021)
  • 5.3.2 Global Neuromodulation Devices and Implantable Infusion Pumps Price Forecast by Application (2022-2027)

6 North America

• 6.1 North America Neuromodulation Devices and Implantable Infusion Pumps Market Size by Type
  • 6.1.1 North America Neuromodulation Devices and Implantable Infusion Pumps Sales by Type (2016-2027)
  • 6.1.2 North America Neuromodulation Devices and Implantable Infusion Pumps Revenue by Type (2016-2027)
• 6.2 North America Neuromodulation Devices and Implantable Infusion Pumps Market Size by Application
  • 6.2.1 North America Neuromodulation Devices and Implantable Infusion Pumps Sales by Application (2016-2027)
  • 6.2.2 North America Neuromodulation Devices and Implantable Infusion Pumps Revenue by Application (2016-2027)
• 6.3 North America Neuromodulation Devices and Implantable Infusion Pumps Market Size by Country
  • 6.3.1 North America Neuromodulation Devices and Implantable Infusion Pumps Sales by Country (2016-2027)
  • 6.3.2 North America Neuromodulation Devices and Implantable Infusion Pumps Revenue by Country (2016-2027)
  • 6.3.3 U.S.
  • 6.3.4 Canada

7 Europe

• 7.1 Europe Neuromodulation Devices and Implantable Infusion Pumps Market Size by Type
  • 7.1.1 Europe Neuromodulation Devices and Implantable Infusion Pumps Sales by Type (2017-2027)
  • 7.1.2 Europe Neuromodulation Devices and Implantable Infusion Pumps Revenue by Type (2017-2027)
• 7.2 Europe Neuromodulation Devices and Implantable Infusion Pumps Market Size by Application
  • 7.2.1 Europe Neuromodulation Devices and Implantable Infusion Pumps Sales by Application (2017-2027)
  • 7.2.2 Europe Neuromodulation Devices and Implantable Infusion Pumps Revenue by Application (2017-2027)
• 7.3 Europe Neuromodulation Devices and Implantable Infusion Pumps Market Size by Country
  • 7.3.1 Europe Neuromodulation Devices and Implantable Infusion Pumps Sales by Country (2017-2027)
  • 7.3.2 Europe Neuromodulation Devices and Implantable Infusion Pumps Revenue by Country (2017-2027)
  • 7.3.3 Germany
  • 7.3.4 France
  • 7.3.5 U.K.
  • 7.3.6 Italy
  • 7.3.7 Russia

8 Asia Pacific

• 8.1 Asia Pacific Neuromodulation Devices and Implantable Infusion Pumps Market Size by Type
  • 8.1.1 Asia Pacific Neuromodulation Devices and Implantable Infusion Pumps Sales by Type (2018-2027)
  • 8.1.2 Asia Pacific Neuromodulation Devices and Implantable Infusion Pumps Revenue by Type (2018-2027)
• 8.2 Asia Pacific Neuromodulation Devices and Implantable Infusion Pumps Market Size by Application
  • 8.2.1 Asia Pacific Neuromodulation Devices and Implantable Infusion Pumps Sales by Application (2018-2027)
  • 8.2.2 Asia Pacific Neuromodulation Devices and Implantable Infusion Pumps Revenue by Application (2018-2027)
• 8.3 Asia Pacific Neuromodulation Devices and Implantable Infusion Pumps Market Size by Region
  • 8.3.1 Asia Pacific Neuromodulation Devices and Implantable Infusion Pumps Sales by Region (2018-2027)
  • 8.3.2 Asia Pacific Neuromodulation Devices and Implantable Infusion Pumps Revenue by Region (2018-2027)
  • 8.3.3 China
  • 8.3.4 Japan
  • 8.3.5 South Korea
  • 8.3.6 India
  • 8.3.7 Australia
  • 8.3.8 Taiwan
  • 8.3.9 Indonesia
  • 8.3.10 Thailand
  • 8.3.11 Malaysia
  • 8.3.12 Philippines

9 Latin America

• 9.1 Latin America Neuromodulation Devices and Implantable Infusion Pumps Market Size by Type
  • 9.1.1 Latin America Neuromodulation Devices and Implantable Infusion Pumps Sales by Type (2019-2027)
  • 9.1.2 Latin America Neuromodulation Devices and Implantable Infusion Pumps Revenue by Type (2019-2027)
• 9.2 Latin America Neuromodulation Devices and Implantable Infusion Pumps Market Size by Application
  • 9.2.1 Latin America Neuromodulation Devices and Implantable Infusion Pumps Sales by Application (2019-2027)
  • 9.2.2 Latin America Neuromodulation Devices and Implantable Infusion Pumps Revenue by Application (2019-2027)
• 9.3 Latin America Neuromodulation Devices and Implantable Infusion Pumps Market Size by Country
  • 9.3.1 Latin America Neuromodulation Devices and Implantable Infusion Pumps Sales by Country (2019-2027)
  • 9.3.2 Latin America Neuromodulation Devices and Implantable Infusion Pumps Revenue by Country (2019-2027)
  • 9.3.3 Mexico
  • 9.3.4 Brazil
  • 9.3.5 Argentina

6 Middle East and Africa

• 6.1 Middle East and Africa Neuromodulation Devices and Implantable Infusion Pumps Market Size by Type
  • 6.1.1 Middle East and Africa Neuromodulation Devices and Implantable Infusion Pumps Sales by Type (2016-2027)
  • 6.1.2 Middle East and Africa Neuromodulation Devices and Implantable Infusion Pumps Revenue by Type (2016-2027)
• 6.2 Middle East and Africa Neuromodulation Devices and Implantable Infusion Pumps Market Size by Application
  • 6.2.1 Middle East and Africa Neuromodulation Devices and Implantable Infusion Pumps Sales by Application (2016-2027)
  • 6.2.2 Middle East and Africa Neuromodulation Devices and Implantable Infusion Pumps Revenue by Application (2016-2027)
• 6.3 Middle East and Africa Neuromodulation Devices and Implantable Infusion Pumps Market Size by Country
  • 6.3.1 Middle East and Africa Neuromodulation Devices and Implantable Infusion Pumps Sales by Country (2016-2027)
  • 6.3.2 Middle East and Africa Neuromodulation Devices and Implantable Infusion Pumps Revenue by Country (2016-2027)
  • 6.3.3 Turkey
  • 6.3.4 Saudi Arabia
  • 6.3.5 U.A.E

11 Company Profiles

• 11.1 Medtronic
  • 11.1.1 Medtronic Corporation Information
  • 11.1.2 Medtronic Overview
  • 11.1.3 Medtronic Neuromodulation Devices and Implantable Infusion Pumps Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.1.4 Medtronic Neuromodulation Devices and Implantable Infusion Pumps Product Description
  • 11.1.5 Medtronic Related Developments
• 11.2 Boston Scientific Corporation
  • 11.2.1 Boston Scientific Corporation Corporation Information
  • 11.2.2 Boston Scientific Corporation Overview
  • 11.2.3 Boston Scientific Corporation Neuromodulation Devices and Implantable Infusion Pumps Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.2.4 Boston Scientific Corporation Neuromodulation Devices and Implantable Infusion Pumps Product Description
  • 11.2.5 Boston Scientific Corporation Related Developments
• 11.3 Abbott
  • 11.3.1 Abbott Corporation Information
  • 11.3.2 Abbott Overview
  • 11.3.3 Abbott Neuromodulation Devices and Implantable Infusion Pumps Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.3.4 Abbott Neuromodulation Devices and Implantable Infusion Pumps Product Description
  • 11.3.5 Abbott Related Developments
• 11.4 Synapse Biomedical
  • 11.4.1 Synapse Biomedical Corporation Information
  • 11.4.2 Synapse Biomedical Overview
  • 11.4.3 Synapse Biomedical Neuromodulation Devices and Implantable Infusion Pumps Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.4.4 Synapse Biomedical Neuromodulation Devices and Implantable Infusion Pumps Product Description
  • 11.4.5 Synapse Biomedical Related Developments
• 11.5 Nevro Corporation
  • 11.5.1 Nevro Corporation Corporation Information
  • 11.5.2 Nevro Corporation Overview
  • 11.5.3 Nevro Corporation Neuromodulation Devices and Implantable Infusion Pumps Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.5.4 Nevro Corporation Neuromodulation Devices and Implantable Infusion Pumps Product Description
  • 11.5.5 Nevro Corporation Related Developments
• 11.6 Neuropace
  • 11.6.1 Neuropace Corporation Information
  • 11.6.2 Neuropace Overview
  • 11.6.3 Neuropace Neuromodulation Devices and Implantable Infusion Pumps Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.6.4 Neuropace Neuromodulation Devices and Implantable Infusion Pumps Product Description
  • 11.6.5 Neuropace Related Developments
• 11.7 Cyberonics
  • 11.7.1 Cyberonics Corporation Information
  • 11.7.2 Cyberonics Overview
  • 11.7.3 Cyberonics Neuromodulation Devices and Implantable Infusion Pumps Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.7.4 Cyberonics Neuromodulation Devices and Implantable Infusion Pumps Product Description
  • 11.7.5 Cyberonics Related Developments
• 11.8 Autonomic Technologies
  • 11.8.1 Autonomic Technologies Corporation Information
  • 11.8.2 Autonomic Technologies Overview
  • 11.8.3 Autonomic Technologies Neuromodulation Devices and Implantable Infusion Pumps Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.8.4 Autonomic Technologies Neuromodulation Devices and Implantable Infusion Pumps Product Description
  • 11.8.5 Autonomic Technologies Related Developments
• 11.9 Avery Biomedical
  • 11.9.1 Avery Biomedical Corporation Information
  • 11.9.2 Avery Biomedical Overview
  • 11.9.3 Avery Biomedical Neuromodulation Devices and Implantable Infusion Pumps Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.9.4 Avery Biomedical Neuromodulation Devices and Implantable Infusion Pumps Product Description
  • 11.9.5 Avery Biomedical Related Developments
• 11.10 Greatbatch Medical
  • 11.10.1 Greatbatch Medical Corporation Information
  • 11.10.2 Greatbatch Medical Overview
  • 11.10.3 Greatbatch Medical Neuromodulation Devices and Implantable Infusion Pumps Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.10.4 Greatbatch Medical Neuromodulation Devices and Implantable Infusion Pumps Product Description
  • 11.10.5 Greatbatch Medical Related Developments
• 11.1 Medtronic
  • 11.1.1 Medtronic Corporation Information
  • 11.1.2 Medtronic Overview
  • 11.1.3 Medtronic Neuromodulation Devices and Implantable Infusion Pumps Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.1.4 Medtronic Neuromodulation Devices and Implantable Infusion Pumps Product Description
  • 11.1.5 Medtronic Related Developments

12 Value Chain and Sales Channels Analysis

• 12.1 Neuromodulation Devices and Implantable Infusion Pumps Value Chain Analysis
• 12.2 Neuromodulation Devices and Implantable Infusion Pumps Key Raw Materials
  • 12.2.1 Key Raw Materials
  • 12.2.2 Raw Materials Key Suppliers
• 12.3 Neuromodulation Devices and Implantable Infusion Pumps Production Mode & Process
• 12.4 Neuromodulation Devices and Implantable Infusion Pumps Sales and Marketing
  • 12.4.1 Neuromodulation Devices and Implantable Infusion Pumps Sales Channels
  • 12.4.2 Neuromodulation Devices and Implantable Infusion Pumps Distributors
• 12.5 Neuromodulation Devices and Implantable Infusion Pumps Customers

13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis

• 13.1 Neuromodulation Devices and Implantable Infusion Pumps Industry Trends
• 13.2 Neuromodulation Devices and Implantable Infusion Pumps Market Drivers
• 13.3 Neuromodulation Devices and Implantable Infusion Pumps Market Challenges
• 13.4 Neuromodulation Devices and Implantable Infusion Pumps Market Restraints

14 Key Findings in The Global Neuromodulation Devices and Implantable Infusion Pumps Study

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
  • 15.1.2 Data Source
• 15.2 Author Details